Current status of immunological therapies for rheumatoid arthritis with a focus on antigen-specific therapeutic vaccines

Rheumatoid arthritis (RA) is recognized as an autoimmune joint disease driven by T cell responses to self (or modified self or microbial mimic) antigens that trigger and aggravate the inflammatory condition. Newer treatments of RA employ monoclonal antibodies or recombinant receptors against cytokin...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Daniel H. Zimmerman, Zoltan Szekanecz, Adrienn Markovics, Kenneth S. Rosenthal, Roy E. Carambula, Katalin Mikecz
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2024-03-01
coleção:	Frontiers in Immunology
Assuntos:	peptide vaccine immunotherapy rheumatoid arthritis cytokines proteoglycan (PG aggrecan)
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fimmu.2024.1334281/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!